APOE and atherosclerosis: To determine whether the administration of recombinant IL-27 affects the initiation of atherosclerosis, we treated 6-week-old ApoE−/− mice with IL-27/anti-IL-27p28-Ab/PBS while they were fed a high-fat diet for 8 weeks.